* Correspondence: Alicja Skrobucha [email protected] Senior authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Furthermore, sex-specific high-intensity signals were found, with males primarily experiencing gastrointestinal disorders and females experiencing general disorders and administration site conditions
With brand-name GLP-1s more accessible, the FDA has issued warnings against using these compounded versions as substitutes
One of the earliest red flags involved anesthesia
The lack of a denominator for the total population taking the medications, where reports came from European and non-European countries, makes it difficult to determine if there is a significant risk
A: While Ozempic and Mounjaro are brand-name medications, there are some compounded semaglutide and tirzepatide formulations available through specialized pharmacies
